EvolveX
Body contour. Muscle tone. A considered approach.
A non-invasive body platform with hands-free applicators for skin heating and muscle stimulation. Tite, Tone and Transform allow different combinations of radiofrequency and electrical muscle stimulation.
Your medical assessment determines suitability.
Understand the platform.
Hands-free bipolar RF & electrical muscle stimulation
Manufacturer information- 01Tite: bipolar radiofrequency
- 02Tone: electrical muscle stimulation
- 03Transform: combined RF & EMS
Areas of application
Body skin laxity · Muscle tone · Body contour
An informed choice.
What the evidence can tell you — and where its limits matter.
Sources checkedEvidence & expectations
Radiofrequency heating and electrical muscle stimulation are separate mechanisms. The FDA describes non-invasive body contouring as a change in localized shape or tone, not a treatment for obesity or a weight-loss method. Effects can be temporary and depend on the technology and site.[1]
Preparation & recovery
Discuss implants, previous procedures and any condition affecting the treatment area. Ask what sensations and visible changes to expect, and how the proposed applicator determines recovery and follow-up.[1]
Risks & limitations
Energy-based procedures can cause pain, swelling, burns or unwanted tissue effects. Eligibility and risks depend on the modality and body site. Non-invasive does not mean risk-free or equivalent to surgery.[1]
Compare your options
Compare a skin-firmness goal with muscle activation and localized fat reduction. Tite, Tone and Transform are not interchangeable labels. Discuss the applicator’s intended purpose instead of assuming every mode produces all three effects.[1]
Different approaches to discuss
These links explain different targets. They are not personalised recommendations.
EvolveX TiteEvolveX ToneEvolveX TransformSources & further reading
- Regulatory safety informationNon-invasive body contouring technologiesFDA
- Manufacturer informationEvolveX: platform informationInModeManufacturer information explains the platform or named protocol; it is not independent evidence of clinical benefit.
How we use evidence
A controlled trial compares interventions in defined groups; an uncontrolled cohort cannot, alone, establish causality. A review depends on the quality of its included studies. We distinguish these sources from manufacturer information and identify when findings do not directly apply to the platform or protocol.
The date records when sources were checked for this guide. It is not a statement of individual clinical review, product authorisation or confirmation of the clinic’s available configuration.
This guide supports a conversation with your clinician. It does not determine your suitability or replace individual aftercare instructions.
Regulatory sources describe their own jurisdictions; a US authorisation or warning does not determine a product’s legal status in Portugal.
Where this technology fits.
Explore the treatment pathways that use this platform, including the sequence and what to discuss at your assessment.